melanoma

ORLANDO, Fla. — A personalized mRNA-based cancer vaccine, when combined with Merck cancer therapy Keytruda, resulted in a statistically significant improvement in recurrence-free survival in people who had surgery to remove a cancerous tumor, compared with using Keytruda alone. That... Read More